Peter Robinson 2024-05-14 Peter Robinson 2024-05-14

Advanced Screening Method for Early Detection of Type 1 Diabetes Exceeds Traditional Standards

Peter Robinson 2024-04-04 Peter Robinson 2024-04-04

Enable Biosciences Appoints Will Robberts as Chief Financial Officer and Secures Strategic Funding

Peter Robinson 2024-02-12 Peter Robinson 2024-02-12

Enable Biosciences Publishes Study Revealing ADAP Technology's Improved Accuracy in T1D Risk Prediction

Peter Robinson 2024-01-23 Peter Robinson 2024-01-23

Enable Biosciences Launches 'Kit to Clinics' with Rigorously Vetted ADAP Technology for Diabetes Care

Peter Robinson 2024-01-03 Peter Robinson 2024-01-03

Enable Biosciences Inc. Reveals Key Findings on COVID-19 Transmission from Mothers to Newborns

Peter Robinson 2023-12-19 Peter Robinson 2023-12-19

Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology

Peter Robinson 2023-03-21 Peter Robinson 2023-03-21

Enable Biosciences Announces Relaunch of Website for Early Detection of Type 1 Diabetes

Peter Robinson 2022-11-10 Peter Robinson 2022-11-10

Enable Biosciences Participates in JDRF One Walk to Raise Funds for Type 1 Diabetes

Peter Robinson 2022-11-03 Peter Robinson 2022-11-03

Enable Biosciences to Co-Sponsor Paris Diabetes Conference

Peter Robinson 2022-10-17 Peter Robinson 2022-10-17

Enable Biosciences Joins the JDRF One Walk to Raise Funds and Awareness for Type 1 Diabetes

Peter Robinson 2022-10-07 Peter Robinson 2022-10-07

Enable Biosciences’ Co-founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry

Peter Robinson 2022-07-22 Peter Robinson 2022-07-22

Detecting immunity to different COVID variants just got a whole lot easier. And soon for Monkeypox too.

Peter Robinson 2022-07-07 Peter Robinson 2022-07-07

Enable Biosciences Clinical Reference Lab Receives Approval to Operate in Maryland

Peter Robinson 2022-06-23 Peter Robinson 2022-06-23

Enable Biosciences and California Department of Public Health Issue First Peer-Reviewed Publication from Statewide Serosurvey

Peter Robinson 2022-06-10 Peter Robinson 2022-06-10

Enable Biosciences, Lund University Report High-Performing Immunoassay for Type 1 Diabetes and Celiac Disease

Guest User 2022-02-24 Guest User 2022-02-24

Enable Biosciences Clinical Reference Lab Accredited by the College of American Pathologists (CAP)

Enable Biosciences Clinical Reference Lab has been accredited by the College of American Pathologists (CAP)

Guest User 2022-01-05 Guest User 2022-01-05

Enable-supported Serosurvey in the News

Peter Robinson 2021-12-15 Peter Robinson 2021-12-15

Enable-supported CalScope Serosurvey Program Issues First Preprint

Guest User 2021-09-30 Guest User 2021-09-30

UCSF Health Awards 2021: Breakthrough COVID-19 Technology Finalist

Enable Biosciences is proud to announce we were selected from hundreds of companies as a Finalist in the Breakthrough COVID-19 category for a UCSF Health Award. The UCSF Health Awards honor outstanding health technologies and innovations dramatically transforming healthcare.

Guest User 2021-06-29 Guest User 2021-06-29

Enable Biosciences to Support California Department of Public Health’s Calscope Program to Survey Covid-19 Antibodies from Infection and Vaccination

June 29, South San Francisco, CA. Enable Biosciences, a South San Francisco diagnostics company and clinical lab, is partnering with the California Department of Public Health (CDPH) in a statewide serosurvey program. CalScope will invite more than 200,000 households to submit dried blood samples collected at home using kits co-developed with CDPH and Enable. The samples will then be sent to Enable’s South San Francisco lab and tested for the presence of antibodies against SARS-CoV-2, the virus that causes COVID-19.